Liposome

A liposome is a very tiny, fat-like particle that is made in the laboratory. In medicine, liposomes containing drugs or other substances are used in the treatment of cancer and other diseases. Drugs given in liposomes may have fewer side effects and work better than the same drugs given alone.
What is a Liposome?

A liposome is a spherical-shaped vesicle that is composed of one or more phospholipid bilayers, which closely resembles the structure of cell membranes. The ability of liposomes to encapsulate hydrophilic or lipophilic drugs have allowed these vesicles to become useful drug delivery systems.

Read More

Overview

Feature Articles

Latest Liposome News and Research

Curia unveils comprehensive mRNA solution

Curia unveils comprehensive mRNA solution

Research suggests targeting fusion peptide-calcium interaction may help treat COVID-19

Research suggests targeting fusion peptide-calcium interaction may help treat COVID-19

Freeze-dried liposomes could be used in potential COVID-19 vaccines

Freeze-dried liposomes could be used in potential COVID-19 vaccines

Scientists pave the way for creating 'mini biological computers' in droplets

Scientists pave the way for creating 'mini biological computers' in droplets

ICL fluorescent label homogenously penetrates the glioblastoma brain tumors

ICL fluorescent label homogenously penetrates the glioblastoma brain tumors

Study examines the effectiveness of fluorescent labels used to monitor liposome accumulation in tumors

Study examines the effectiveness of fluorescent labels used to monitor liposome accumulation in tumors

Precision medicine may lead to more effective treatments for ocular conditions

Precision medicine may lead to more effective treatments for ocular conditions

The Role of Nanoparticles for Drug Delivery

The Role of Nanoparticles for Drug Delivery

A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity

A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice

A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

Novel method instructs immune cells to help repair damaged tissues in the intestine

Novel method instructs immune cells to help repair damaged tissues in the intestine

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Insulin nanoparticles may become an alternative to insulin injections for diabetic patients

Insulin nanoparticles may become an alternative to insulin injections for diabetic patients

PVP at Boston Children's awarded $1 million to extend research into adjuvant-based vaccines

PVP at Boston Children's awarded $1 million to extend research into adjuvant-based vaccines

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

New method using light-activated liposomes is safer, more direct to deliver CRISPR gene therapy

New method using light-activated liposomes is safer, more direct to deliver CRISPR gene therapy

Nafamostat mesylate initially reduces SARS-CoV-2 viral loads in hamsters, study finds

Nafamostat mesylate initially reduces SARS-CoV-2 viral loads in hamsters, study finds